GlassScriptPhysician profile
Selena Beal
NPI 1801624788
$5,665.64
in general payments reported to CMS, 2019-2025
38 companies · $4,842 in 2025
The $4,842 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $824 · 2025: $4,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,666.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,665.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $595.72 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $494.76 | 2024-2025 | Korlym |
| Radius Health, INC. | $389.14 | 2024-2025 | Tymlos |
| Dexcom, INC. | $338.88 | 2024-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $314.61 | 2024-2025 | Tepezza, Evenity |
| Antares Pharma, INC. | $301.57 | 2024-2025 | Xyosted |
| Lilly USA, LLC | $285.52 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Sanofi-Aventis U.S. LLC | $260.23 | 2025 | |
| Xeris Pharmaceuticals, INC. | $258.52 | 2025 | Gvoke Hypopen, Recorlev |
| Ascendis Pharma Endocrinology INC | $253.70 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $231.31 | 2025 | Twiist |
| Bayer Healthcare Pharmaceuticals INC. | $230.24 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.87 | 2025 | Jardiance |
| Amneal Pharmaceuticals LLC | $184.64 | 2024-2025 | Unithroid |
| Beta Bionics, INC. | $156.76 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $140.57 | 2025 | Freestyle Libre 3 |
| Recordati_rare_diseases_inc. | $138.31 | 2025 | Isturisa |
| Abbvie INC. | $135.02 | 2024-2025 | |
| Mannkind Corporation | $118.91 | 2024-2025 | |
| Tandem Diabetes Care, INC. | $113.28 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $77.64 | 2024-2025 | Omnipod |
| Aimmune Therapeutics, INC. | $50.72 | 2025 | Zenpep |
| Chiesi USA, INC. | $50.56 | 2025 | Mycapssa |
| Rhythm Pharmaceuticals, INC. | $37.00 | 2025 | Imcivree |
| Esperion Therapeutics, INC. | $32.94 | 2024-2025 | Nexletol |
| Madrigal Pharmaceuticals | $30.56 | 2025 | Rezdiffra |
| Almatica Pharma LLC | $30.19 | 2025 | Teriparatide |
| Eisai INC. | $28.56 | 2025 | |
| Tolmar, INC. | $23.15 | 2025 | Jatenzo |
| Astellas Pharma US INC | $22.03 | 2025 | Veozah |
| Regeneron Healthcare Solutions, INC. | $20.41 | 2025 | Evkeeza |
| Soleno Therapeutics, INC. | $19.80 | 2025 | Vykat Xr |
| Alexion Pharmaceuticals, INC. | $19.13 | 2024 | Strensiq |
| Amphastar Pharmaceuticals, INC. | $18.83 | 2025 | |
| Medtronic, INC. | $17.38 | 2024 | Intellis Adaptivestim |
| Vivus LLC | $16.90 | 2025 | Qsymia |
| Acella Pharmaceuticals, LLC | $13.66 | 2025 | NP Thyroid 60 |
| Novartis Pharmaceuticals Corporation | $13.62 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selena Beal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.